Report Materials
EXECUTIVE SUMMARY:
Our objective was to determine whether the Iowa
Department of Human Services's (the
State agency) claims for reimbursement of Medicaid outpatient drug expenditures complied with Federal requirements. Not all of the State agency's claims for reimbursement of Medicaid outpatient drug expenditures complied with Federal requirements. Of the
$709
million ($466
million Federal share)
in Medicaid outpatient drug expenditures that the State agency claimed for
fiscal years 2003 and 2004, $154,245 (
Federal share) represented expenditures for drug products that were
not eligible for Medicaid coverage because they were terminated drugs. An
additional $1,079,386 (Federal share) represented expenditures for drug products
that were not listed on the quarterly drug tapes.
We recommended that the State agency (1) refund $154,245 to the Federal
Government
for drug expenditures that were not eligible for Medicaid coverage; (2) work with CMS to resolve
$1,079,386
in payments for drugs that were not listed on the quarterly drug tapes and that may not have been eligible for Medicaid coverage; and (3)
strengthen internal controls to ensure that
claimed Medicaid drug expenditures comply with Federal requirements,
specifically by claiming expenditures only for drugs that are dispensed before
the termination dates listed on the quarterly drug tapes and verifying whether
drugs not listed on the quarterly drug tapes are covered under the Medicaid
program and notify CMS when drugs are missing from the tapes. The State agency
partly agreed and partly disagreed with our recommendations.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.